DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 45 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$5,968,000
-0.3%
5,950,0000.0%0.01%0.0%
Q2 2021$5,985,000
-0.9%
5,950,0000.0%0.01%
-9.1%
Q1 2021$6,042,000
-7.0%
5,950,0000.0%0.01%
-21.4%
Q4 2020$6,496,000
+10.8%
5,950,000
+4.4%
0.01%0.0%
Q3 2020$5,861,000
-6.9%
5,700,0000.0%0.01%
-17.6%
Q2 2020$6,293,000
+9.1%
5,700,0000.0%0.02%
-15.0%
Q1 2020$5,769,000
-36.5%
5,700,000
-28.3%
0.02%
-16.7%
Q4 2019$9,082,000
+0.0%
7,950,0000.0%0.02%
-11.1%
Q3 2019$9,081,000
-9.1%
7,950,000
-5.9%
0.03%
-12.9%
Q2 2019$9,994,000
+9.9%
8,450,000
+25.2%
0.03%
+3.3%
Q1 2019$9,093,000
+27.9%
6,750,0000.0%0.03%
+7.1%
Q4 2018$7,108,000
-6.3%
6,750,000
-12.9%
0.03%0.0%
Q2 2018$7,585,000
-1.9%
7,750,000
-1.0%
0.03%
-6.7%
Q1 2018$7,733,000
+4.6%
7,825,000
+11.8%
0.03%
+7.1%
Q4 2017$7,390,000
+3.3%
7,000,000
+3.7%
0.03%
-6.7%
Q3 2017$7,153,000
+40.8%
6,750,000
+42.1%
0.03%
+25.0%
Q2 2017$5,079,000
+40.4%
4,750,000
+26.7%
0.02%
+50.0%
Q1 2017$3,617,0003,750,0000.02%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2017
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders